tiprankstipranks
Trending News
More News >
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market

Amylyx Pharmaceuticals Inc (AMLX) Income Statement

Compare
647 Followers

Amylyx Pharmaceuticals Inc Income Statement

Last quarter (Q3 2025), Amylyx Pharmaceuticals Inc's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Amylyx Pharmaceuticals Inc's net income was $-34.39M. See Amylyx Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 87.37M$ 380.79M$ 22.23M$ 0.00$ 650.00K
Gross Profit
$ 45.22M$ 355.35M$ 19.24M$ 0.00$ -23.94M
Operating Expenses
$ 359.95M$ 316.54M$ 220.58M$ 82.69M$ 15.06M
Depreciation and Amortization
$ 904.00K$ 1.09M$ 487.00K$ 52.00K$ 1.00K
EBITDA
$ -290.98M$ 39.89M$ -200.85M$ -82.64M$ -39.00M
Operating Income
$ -314.73M$ 38.80M$ -201.34M$ -82.69M$ -39.01M
Other Income/Expenses
$ 12.60M$ 15.49M$ 3.74M$ -5.24M$ -3.27M
Pretax Income
$ -302.14M$ 54.30M$ -197.60M$ -87.93M$ -42.28M
Net Income
$ -301.74M$ 49.27M$ -198.38M$ -87.93M$ -42.28M
Per Share Metrics
Basic EPS
$ -4.43$ 0.73$ -2.98$ -1.52$ -0.79
Diluted EPS
$ -4.43$ 0.70$ -2.98$ -1.52$ -0.79
Weighted Average Shares Outstanding
68.14M 67.23M 66.51M 57.86M 56.47M
Weighted Average Shares Outstanding (Diluted)
68.14M 69.99M 66.51M 57.86M 56.47M
Currency in USD

Amylyx Pharmaceuticals Inc Earnings and Revenue History